Breast Cancer Profiling Project, Drug Sensitivity phase II: Fixed-cell GR measures of 33 breast cell lines and PDX lines to 16 small molecule perturbagens from library plate II. Dataset 1 of 2: Normalized growth rate inhibition values - Dataset (ID:20354)

Filter results: >>>>
Cell Small Molecule Small Mol Concentration (uM) Mean Normalized Growth Rate Inhibition Value Increased Fraction Dead
MDA-MB-231 Ribociclib
10.0
0.1421 0.02459
MDA-MB-231 Ribociclib
10.0
0.2071 0.02401
MDA-MB-231 Ribociclib
10.0
0.2166 0.03003
MDA-MB-231 LY3023414
0.001
0.7211 0.00401
MDA-MB-231 LY3023414
0.001
0.7634 0.00547
MDA-MB-231 LY3023414
0.001
0.8153 -0.00244
MDA-MB-231 LY3023414
0.003162278
0.5869 -0.00312
MDA-MB-231 LY3023414
0.003162278
0.5782 0.00050
MDA-MB-231 LY3023414
0.003162278
0.5864 0.01000
MDA-MB-231 LY3023414
0.01
0.5674 -0.00077
MDA-MB-231 LY3023414
0.01
0.5721 -0.00278
MDA-MB-231 LY3023414
0.01
0.6069 -0.00056
MDA-MB-231 LY3023414
0.031622777
0.2430 0.19726
MDA-MB-231 LY3023414
0.031622777
0.5056 -0.00321
MDA-MB-231 LY3023414
0.031622777
0.4413 0.01115
MDA-MB-231 LY3023414
0.1
0.3242 0.00065
MDA-MB-231 LY3023414
0.1
0.3650 -0.00362
MDA-MB-231 LY3023414
0.1
0.3799 0.01169
MDA-MB-231 LY3023414
0.316227766
0.3027 0.02478
MDA-MB-231 LY3023414
0.316227766
0.3724 0.01040
MDA-MB-231 LY3023414
0.316227766
0.3616 0.01049
MDA-MB-231 LY3023414
1.0
0.2703 0.00649
MDA-MB-231 LY3023414
1.0
0.2877 -0.00099
MDA-MB-231 LY3023414
1.0
0.2517 -0.00292
MDA-MB-231 LY3023414
3.16227766
0.2045 0.01236